Vanguard (DBD) Amendment Shows 0 Shares After Jan 12, 2026 Realignment
Rhea-AI Filing Summary
The Vanguard Group filed an amendment (Schedule 13G/A) reporting 0 shares of Diebold Nixdorf Inc. common stock. The filing states 0 beneficially owned and 0.00% of the class. It notes an internal realignment on January 12, 2026 that caused disaggregated reporting by Vanguard subsidiaries.
The filing is signed by Ashley Grim as Head of Global Fund Administration on 03/26/2026.
Positive
- None.
Negative
- None.
Insights
Vanguard reports no beneficial ownership after internal disaggregation.
The filing explicitly lists Amount beneficially owned: 0 and Percent of class: 0 %, reflecting Vanguard's disaggregated reporting following an internal realignment on January 12, 2026. The text states certain subsidiaries will report separately in reliance on SEC Release No. 34-39538.
Practical implication: this is a reporting adjustment tied to internal structure rather than a market trade; any future reported holdings will depend on subsidiary-level filings and are not aggregated under The Vanguard Group in this amendment.
FAQ
What does the Schedule 13G/A from The Vanguard Group say about DBD holdings?
When did Vanguard's internal realignment that changed reporting occur?
Who signed the Schedule 13G/A amendment for Vanguard and when?
Does this amendment indicate Vanguard sold or bought Diebold Nixdorf shares?
Is Vanguard reporting any shared or sole voting/dispositive power over DBD shares?